Silver Lake Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.12M Sell
31,985
-418
-1% -$97.4K 2.9% 8
2026
Q1
$7.92M Sell
32,403
-1,252
-4% -$292K 3.14% 6
2025
Q4
$6.96M Sell
33,655
-286
-0.8% -$56.6K 2.7% 8
2025
Q3
$6.29M Sell
33,941
-191
-0.6% -$32.7K 2.51% 11
2025
Q2
$5.21M Buy
34,132
+382
+1% +$58.7K 2.22% 16
2025
Q1
$5.6M Buy
33,750
+320
+1% +$50.1K 2.44% 10
2024
Q4
$4.83M Sell
33,430
-557
-2% -$86.3K 2.13% 16
2024
Q3
$5.51M Buy
33,987
+734
+2% +$117K 2.26% 13
2024
Q2
$4.86M Sell
33,253
-747
-2% -$111K 2.19% 15
2024
Q1
$5.38M Buy
34,000
+339
+1% +$54K 2.4% 13
2023
Q4
$5.28M Sell
33,661
-47
-0.1% -$7.21K 2.96% 9
2023
Q3
$5.25M Buy
33,708
+362
+1% +$59.7K 3.24% 8
2023
Q2
$5.52M Sell
33,346
-132
-0.4% -$21.3K 2.95% 6
2023
Q1
$5.19M Buy
33,478
+370
+1% +$59.7K 2.88% 7
2022
Q4
$5.85M Buy
33,108
+200
+0.6% +$34.5K 3.56% 4
2022
Q3
$5.38M Buy
32,908
+156
+0.5% +$26.4K 3.15% 3
2022
Q2
$5.81M Buy
32,752
+166
+0.5% +$29.6K 3.17% 2
2022
Q1
$5.78M Sell
32,586
-117
-0.4% -$19.9K 2.74% 6
2021
Q4
$5.59M Buy
32,703
+115
+0.4% +$18.8K 2.59% 7
2021
Q3
$5.26M Buy
32,588
+563
+2% +$96.1K 2.59% 5
2021
Q2
$5.58M Sell
32,025
-79
-0.2% -$13.1K 2.67% 4
2021
Q1
$5.28M Buy
32,104
+179
+0.6% +$29K 2.69% 4
2020
Q4
$5.02M Sell
31,925
-1,049
-3% -$155K 2.75% 5
2020
Q3
$4.91M Buy
32,974
+154
+0.5% +$22.8K 3.02% 5
2020
Q2
$4.62M Sell
32,820
-2,567
-7% -$374K 2.95% 5
2020
Q1
$4.64M Buy
35,387
+338
+1% +$48K 3.41% 6
2019
Q4
$5.11M Buy
35,049
+144
+0.4% +$19.5K 3.08% 6
2019
Q3
$4.52M Buy
34,905
+527
+2% +$69.4K 2.92% 7
2019
Q2
$4.79M Buy
34,378
+366
+1% +$50.7K 3.17% 5
2019
Q1
$4.75M Sell
34,012
-1,304
-4% -$175K 3.21% 5
2018
Q4
$4.56M Buy
35,316
+18
+0.1% +$2.51K 3.38% 5
2018
Q3
$4.88M Buy
35,298
+531
+2% +$70.6K 2.96% 4
2018
Q2
$4.6M Sell
34,767
-188
-0.5% -$23.5K 3.66% 3
2018
Q1
$4.48M Buy
34,955
+124
+0.4% +$16.8K 3.33% 6
2017
Q4
$4.87M Sell
34,831
-12
-0% -$1.67K 3.47% 3
2017
Q3
$4.53M Sell
34,843
-667
-2% -$88.4K 3.45% 2
2017
Q2
$4.7M Buy
35,510
+74
+0.2% +$9.44K 3.48% 2
2017
Q1
$4.41M Sell
35,436
-829
-2% -$99K 3.32% 3
2016
Q4
$4.18M Sell
36,265
-258
-0.7% -$29.8K 3.23% 3
2016
Q3
$4.31M Buy
36,523
+98
+0.3% +$11.9K 3.22% 5
2016
Q2
$4.42M Buy
36,425
+427
+1% +$48.5K 3.29% 5
2016
Q1
$3.9M Sell
35,998
-35
-0.1% -$3.62K 3.32% 5
2015
Q4
$3.7M Buy
36,033
+11
+0% +$1.11K 3.31% 6
2015
Q3
$3.36M Sell
36,022
-284
-0.8% -$27.5K 3.03% 6
2015
Q2
$3.54M Buy
36,306
+2,201
+6% +$220K 2.87% 7
2015
Q1
$3.43M Buy
34,105
+7,970
+30% +$810K 2.76% 7
2014
Q4
$2.73M Buy
26,135
+2,034
+8% +$214K 2.22% 14
2014
Q3
$2.57M Buy
24,101
+110
+0.5% +$11.4K 2.11% 15
2014
Q2
$2.46M Buy
23,991
+128
+0.5% +$12.9K 2.03% 16
2014
Q1
$2.34M Buy
23,863
+405
+2% +$37.5K 2.1% 16
2013
Q4
$2.15M Buy
+23,458
New +$2.16M 1.83% 21

Other funds holding JNJ

Silver Lake Advisory's JNJ Position: Q2 2026 in Review

Silver Lake Advisory reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q2 2026, selling an estimated $97.4K and leaving 31,985 shares worth $8.12M. The position accounts for 2.9% of the portfolio, ranked #8.

Silver Lake Advisory first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Silver Lake Advisory held 31,985 shares of Johnson & Johnson worth $8.12M as of Q2 2026.
  • Silver Lake Advisory sold 418 Johnson & Johnson shares in Q2 2026, an estimated $97.4K.
  • Johnson & Johnson made up 2.9% of Silver Lake Advisory's portfolio in Q2 2026, its #8 holding.
  • Silver Lake Advisory first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Silver Lake Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.